Medical News

RSS

Inflammation has ‘etiologic link’ with prostate cancer

Chronic inflammation of prostate tissue is strongly associated with subsequent development of prostate cancer, show results of a US observational study.

28 Apr 2014

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").

28 Apr 2014

Emilia Group completes acquisition of Pharma Pac's strategic assets

Emilia Group is pleased to announce the recent acquisition of strategic assets of Pharma Pac LLC, an OTC private brand and contract manufacturer, located in DeKalb, MS. The new entity is named Emilia Resources LLC and will operate as a manufacturing company of pharmaceutical and cosmetic products that will combine with Emilia Personal Care's strength in sales, marketing, supply chain and customer service.

28 Apr 2014

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.

28 Apr 2014

Sorin Group's Mitroflow Aortic Pericardial Heart Valve with PRT gets approval from FDA

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.

28 Apr 2014

Young onset age heightens Type 2 diabetes complication risks

Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.

28 Apr 2014

Cognitive deficits stable across bipolar disease course

The cognitive deficits experienced by patients with bipolar disorder are relatively stable across the disease course, show findings from a meta-analysis involving 14 studies.

28 Apr 2014

Deprivation–schizophrenia link accounted for by crime, low education

Study results indicate that the association between area deprivation and first-onset schizophrenia could be accounted for by high crime and low education levels.

28 Apr 2014

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Truven Health Analytics, a leading provider of healthcare analytics and data solutions and services, today announced the acquisition of Fortel Analytics' healthcare fraud technology. The acquisition gives Truven Health exclusive access to a breakthrough suite of predictive solutions, analysis methods and analytic technology designed to quickly identify suspicious patterns in healthcare insurance claims data before claims are ever paid.

28 Apr 2014

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.

28 Apr 2014

Forest Laboratories enters into definitive agreement to acquire Furiex

Forest Laboratories, Inc. nd Furiex Pharmaceuticals, Inc. today announced that Forest has entered into a definitive agreement to acquire Furiex, a drug development collaboration company, for $95 per share, or approximately $1.1 billion in cash, and up to $30 per share (approximately $360 million in aggregate) in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

First Edition: April 28, 2014

Today's headlines include a number of stories examining the impact of the health law in various states.

28 Apr 2014

Agenus enters into agreement with Merck for development of therapeutic antibodies

Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.

28 Apr 2014

Scientists use analysis of epigenetic marks on DNA to measure baby's development in womb

An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.

28 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

Sinovac Biotech commits to commercialize Sabin Inactivated Polio Vaccine in China

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has entered into a license agreement with Intravacc (Institute for Translational Vaccinology) from The Netherlands to develop and commercialize the Sabin Inactivated Polio Vaccine (sIPV) for distribution to China and other countries.

28 Apr 2014

Medical News

Inflammation has ‘etiologic link’ with prostate cancer

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Emilia Group completes acquisition of Pharma Pac's strategic assets

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Sorin Group's Mitroflow Aortic Pericardial Heart Valve with PRT gets approval from FDA

Young onset age heightens Type 2 diabetes complication risks

Cognitive deficits stable across bipolar disease course

Deprivation–schizophrenia link accounted for by crime, low education

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Forest Laboratories enters into definitive agreement to acquire Furiex

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

First Edition: April 28, 2014

Agenus enters into agreement with Merck for development of therapeutic antibodies

Scientists use analysis of epigenetic marks on DNA to measure baby's development in womb

Voluntis closes €20.75 million ($29 million) Series D financing round

Sinovac Biotech commits to commercialize Sabin Inactivated Polio Vaccine in China

Cancer Council Queensland welcomes proposed changes to cervical screening program

Mauna Kea receives regulatory approval in Japan for Cellvizio flagship product

Alcohol and drugs put teens at increased risk for unsafe driving

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News